Identification of a hypoxic population of bone marrow cells
Description
A technique using collagenase has been devised to release and separate, with reproducibility, hematopoietic cells (HC) from various microenvironments of mouse femurs. HC were assayed by an in vitro gel culture technique used traditionally to score granulocyte-macrophage precursor cells (CFU-C). CFU-C which resided in the medullary cavity and endosteal regions were sensitive to ionizing radiation and resistant to misonidazole (MISO) cytotoxicity. CFU-C which resided within the compact bone were resistant to ionizing radiation and sensitive to the cytotoxic action of MISO. These results suggest that HC which reside in the bone are hypoxic and retain clonogenic potential. When animals were exposed to various treatments with MISO followed by myelotoxic doses of cyclophosphamide (CTX) or total body irradiation (TBI), the LD/sub 50/ of both agents was significantly reduced. This result suggests that a hypoxic component of HC could be important in the regenerative process within the marrow after such myelotoxic trauma
Additional details
Publishing Information
- Journal Title
- Int. J. Radiat. Oncol., Biol. Phys.
- Journal Volume
- 9
- Journal Issue
- 2
- Series
- Int. J. Radiat. Oncol., Biol. Phys.
- Journal Page Range
- 227-232
- ISSN
- 0360-3016
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 15024468
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANOXIA; BONE MARROW CELLS; CFU; CHEMOTHERAPY; ENDOXAN; IN VITRO; IONIZING RADIATIONS; MISONIDAZOLE; RADIOSENSITIVITY; RADIOTHERAPY
- Descriptors DEC
- ALCOHOLS; ALKYLATING AGENTS; ANIMAL CELLS; ANTIMITOTIC DRUGS; ANTINEOPLASTIC DRUGS; AZOLES; CONNECTIVE TISSUE CELLS; DRUGS; HETEROCYCLIC COMPOUNDS; HYDROXY COMPOUNDS; IMIDAZOLES; MEDICINE; NITRO COMPOUNDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; RADIATIONS; RADIOSENSITIZERS; RESPONSE MODIFYING FACTORS; SOMATIC CELLS; THERAPY